AKT1 and meningioma: Boetto et al. (2017) showed that SMO-mutated meningiomas had a higher recurrence rate with respect to AKT1 mutated-meningiomas and that, overall, SMO-mutated meningiomas had a poor prognosis as compared to AKT1-mutated ones [327].